# KALA BIO, Inc.: Form 8-K/A, filed Oct 2, 2025

- Company: [KALA BIO, Inc.](/companies/kala.md) (CIK 1479419)
- Form: 8-K/A
- Filed: 2025-10-02
- Accepted by EDGAR: Oct 2, 2025, 16:15 ET
- Period: 2025-09-28
- Accession: 0001104659-25-096071
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1479419/000110465925096071/tm2527808d1_8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1479419/000110465925096071/

## Items reported

- Item 2.05: Exit or disposal costs
- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1479419/000110465925096071/tm2527808d1_8ka.htm

Filed Oct 2, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-096071. Last ingested by Listed: Nov 9, 2026, 18:14 ET. No prices; not investment advice.